$69.1B
$7.78 Million
0.0% of portfolio
105
Q2 2023
New
$14.9B
$7.18 Million
0.0% of portfolio
152
Q2 2023
New
$28.5B
$1.19 Million
0.0% of portfolio
20
Q3 2024
New
Oncternal Therapeutics Incorporated Com New
-
$27,000
0.0% of portfolio
-
Q1 2024
New
$263M
$2.76 Million
0.0% of portfolio
1,747
Q2 2023
New
$61B
$14.2 Million
0.0% of portfolio
14
Q3 2023
New
$54.6B
$126,000
0.0% of portfolio
2
Q2 2024
Reduced 98.73%
$440M
$26.3 Million
0.0% of portfolio
4,930
Q4 2023
Reduced 10.04%
$2.5B
$350,000
0.0% of portfolio
13
Q2 2023
New
$1.16B
$821,000
0.0% of portfolio
73
Q3 2023
Added 2.82%
$3.29B
$2.51 Million
0.0% of portfolio
521
Q3 2024
Reduced 0.19%
$10.2B
$3.02 Million
0.0% of portfolio
40
Q2 2023
New
$25.7B
$4.28 Million
0.0% of portfolio
22
Q2 2023
New
$49.2B
$21.7 Million
0.0% of portfolio
317
Q3 2024
Reduced 0.31%
$25.8B
$33.1 Million
0.0% of portfolio
2,370
Q3 2024
Reduced 0.42%
$7.95B
$16.9 Million
0.0% of portfolio
58
Q3 2024
Added 23.4%
$414M
$1.69 Million
0.0% of portfolio
238
Q3 2023
Reduced 94.56%
$6.53B
$268,000
0.0% of portfolio
5
Q3 2024
Reduced 75.0%
$541M
$282,000
0.0% of portfolio
13
Q3 2024
New
$0
$960,000
0.0% of portfolio
173
Q3 2024
New
$0
$17.3 Million
0.0% of portfolio
3,311
Q4 2023
New
$539M
$497,000
0.0% of portfolio
50
Q1 2024
Reduced 88.89%
Ge Healthcare Technologies Incorporated Common Stock
-
$21.7 Million
0.0% of portfolio
-
Q3 2024
Reduced 52.4%
Genprex Incorporated Com New
-
$745,000
0.0% of portfolio
-
Q1 2024
New
$7.15B
$7.3 Million
0.0% of portfolio
202
Q1 2024
Added 0.5%
$5.8B
$583,000
0.0% of portfolio
10
Q2 2023
New
$0
$3.4 Million
0.0% of portfolio
100
Q1 2024
New
$0
$2.27 Million
0.0% of portfolio
50
Q2 2023
New
$0
$2.52 Million
0.0% of portfolio
125
Q2 2023
New
$84.2B
$9.39 Million
0.0% of portfolio
35
Q3 2023
Reduced 7.89%
$41.9B
$27.7 Million
0.0% of portfolio
292
Q2 2024
Reduced 59.44%
$0
$1.97 Million
0.0% of portfolio
29
Q1 2024
Added 190.0%
$0
$228,000
0.0% of portfolio
5
Q3 2024
New
$0
$7.84 Million
0.0% of portfolio
80
Q2 2024
Reduced 6.98%
$0
$1.1 Million
0.0% of portfolio
46
Q3 2024
Reduced 14.81%
$0
$1.09 Million
0.0% of portfolio
47
Q3 2024
Reduced 14.55%
$0
$1.09 Million
0.0% of portfolio
48
Q3 2024
Reduced 14.29%
$0
$1.11 Million
0.0% of portfolio
50
Q3 2024
Reduced 15.25%
$0
$822,000
0.0% of portfolio
20
Q2 2023
New
$0
$19.7 Million
0.0% of portfolio
120
Q1 2024
Added 60.0%
$0
$16.8 Million
0.0% of portfolio
520
Q4 2023
Reduced 36.27%
$0
$11.5 Million
0.0% of portfolio
34
Q3 2024
Reduced 65.31%
$0
$445,000
0.0% of portfolio
6
Q2 2024
Reduced 97.66%
$0
$348,000
0.0% of portfolio
6
Q3 2024
New
$21.1B
$5.62 Million
0.0% of portfolio
144
Q2 2023
New
$180B
$7.25 Million
0.0% of portfolio
11
Q1 2024
Reduced 47.62%
$0
$18.7 Million
0.0% of portfolio
110
Q3 2024
Reduced 0.9%
$0
$23.5 Million
0.0% of portfolio
667
Q4 2023
Reduced 11.54%
$0
$31.9 Million
0.0% of portfolio
300
Q3 2024
New
$0
$2.22 Million
0.0% of portfolio
34
Q1 2024
Added 3.03%